Publikasi Scopus 2023 per tanggal 31 Juli 2023 (506 artikel)

Keumala Budianti W.; Mahri S.; Almira D.
58289898700; 57608024500; 58290665100
The Role of Adjuvant Therapy in the Management of Chronic Urticaria; [[Artículo traducido] El papel de la terapia adyuvante en el tratamiento de la urticaria crónica espontánea]
2023
Actas Dermo-Sifiliograficas
114
6
T523
T530
7
0
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo, Jakarta, Indonesia
Keumala Budianti W., Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo, Jakarta, Indonesia; Mahri S., Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo, Jakarta, Indonesia; Almira D., Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo, Jakarta, Indonesia
Recent guideline on the management of urticaria recommends second-generation H1-antihistamine as the first-line therapy, with dose increases of up to fourfold if inadequately controlled. However, the treatment of chronic spontaneous urticaria (CSU) is often disappointing, so additional adjuvant therapies are needed to increase the effectiveness of first-line therapy, especially in patients who are refractory to the increase of antihistamine doses. Recent studies recommend various adjuvant therapy modalities for CSU, such as biological agents, immunosuppressants, leukotriene receptor antagonists, H2-antihistamine, sulfones, autologous serum therapy, phototherapy, vitamin D, antioxidants, and probiotics. This literature review was made to determine the effectiveness of various adjuvant therapies in managing CSU. © 2023 AEDV
Adjuvant therapy; Chronic spontaneous urticaria; Complementary therapy
antihistaminic agent; antioxidant; immunosuppressive agent; leukotriene receptor blocking agent; probiotic agent; sulfone; vitamin D; adjuvant therapy; adult; chronic spontaneous urticaria; chronic urticaria; controlled study; drug efficacy; first-line treatment; human; human tissue; phototherapy; practice guideline; Review; urticaria
Elsevier Doyma
00017310
Review
Q3
279
15467